Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Spicer

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
The Annals of Thoracic Surgery|July 2, 2021
The Case for Periadjuvant Therapy in Early-stage Lung CancerJonathan D Spicer
The Journal of Thoracic and Cardiovascular Surgery|March 26, 2019
Commentary: The path to prophylaxis for predictable palpitationsJonathan D Spicer
The Journal of Thoracic and Cardiovascular Surgery|April 28, 2023
Turning the tides on the perioperative care of resectable lung cancerJoseph Seitlinger, Jonathan D Spicer
The Journal of Pathology|December 3, 2021
Pancancer cytotoxic T-cell trapping: are neutrophil extracellular traps a viable biomarker for immunotherapy response?<sup>†</sup>Lysanne Desharnais, Jonathan D Spicer
Thoracic Surgery Clinics|November 19, 2025
Neoadjuvant ChemoimmunotherapyGökce Yavuz, Jonathan D Spicer
Seminars in Immunology|February 7, 2022
The role of neutrophil extracellular traps in cancer progression and metastasisMeghan L De Meo, Jonathan D Spicer
JAMA Oncology|September 26, 2024
Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer-ReplyMark Sorin, Connor Prosty, Jonathan D Spicer
Cancer Cell|August 12, 2020
Neutrophil DNA Webs UntangledSimon Milette, Daniela F Quail, Jonathan D Spicer
Translational Lung Cancer Research|February 11, 2021
Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancerCaroline Huynh, Logan A Walsh, Jonathan D Spicer
The New England Journal of Medicine|August 8, 2024
Perioperative Nivolumab in Resectable Lung Cancer. ReplyTina Cascone, Jonathan D Spicer, Mariano Provencio Pulla
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
The Annals of Thoracic Surgery|July 2, 2021
The Case for Periadjuvant Therapy in Early-stage Lung CancerJonathan D Spicer
The Journal of Thoracic and Cardiovascular Surgery|March 26, 2019
Commentary: The path to prophylaxis for predictable palpitationsJonathan D Spicer
The Journal of Thoracic and Cardiovascular Surgery|April 28, 2023
Turning the tides on the perioperative care of resectable lung cancerJoseph Seitlinger, Jonathan D Spicer
The Journal of Pathology|December 3, 2021
Pancancer cytotoxic T-cell trapping: are neutrophil extracellular traps a viable biomarker for immunotherapy response?<sup>†</sup>Lysanne Desharnais, Jonathan D Spicer
Thoracic Surgery Clinics|November 19, 2025
Neoadjuvant ChemoimmunotherapyGökce Yavuz, Jonathan D Spicer
Seminars in Immunology|February 7, 2022
The role of neutrophil extracellular traps in cancer progression and metastasisMeghan L De Meo, Jonathan D Spicer
JAMA Oncology|September 26, 2024
Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer-ReplyMark Sorin, Connor Prosty, Jonathan D Spicer
Cancer Cell|August 12, 2020
Neutrophil DNA Webs UntangledSimon Milette, Daniela F Quail, Jonathan D Spicer
Translational Lung Cancer Research|February 11, 2021
Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancerCaroline Huynh, Logan A Walsh, Jonathan D Spicer
The New England Journal of Medicine|August 8, 2024
Perioperative Nivolumab in Resectable Lung Cancer. ReplyTina Cascone, Jonathan D Spicer, Mariano Provencio Pulla
Pageof 8